John R. Jacobsen - 01 Jun 2023 Form 4 Insider Report for DICE Therapeutics, Inc.

Role
CSO
Signature
/s/ Scott Robertson as attorney-in-fact for John R. Jacobsen
Issuer symbol
N/A
Transactions as of
01 Jun 2023
Net transactions value
-$572,444
Form type
4
Filing time
02 Jun 2023, 20:11:36 UTC
Previous filing
19 Apr 2023
Next filing
09 Aug 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DICE Common Stock Sale $433,645 -14,307 -8.6% $30.31 151,940 01 Jun 2023 Direct F1, F2
transaction DICE Common Stock Sale $138,799 -4,443 -2.9% $31.24 147,497 01 Jun 2023 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 27, 2022.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.71 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.